Jiangsu Shimeikang Pharmaceutical

Jiangsu Shimeikang Pharmaceutical is a pharmaceutical company based in Taizhou, China, located within the China Medical City industrial cluster. The company focuses on the development, manufacturing, and commercialization of chemical drug preparations across several key therapeutic areas, including cardiovascular, metabolic, and infectious diseases. Its commercial portfolio features essential medicines such as Amlodipine Besylate for hypertension and Metformin Hydrochloride for diabetes management. Shimeikang maintains large-scale production facilities that adhere to national GMP standards, supporting its role as a significant provider of high-quality generic medications in the Chinese healthcare market.